跳至主要内容
临床试验/JPRN-UMIN000005593
JPRN-UMIN000005593招募中未知

Fever and Antipyretic in Critically ill Evaluation :phase II randomized controlled trial (FACE II trial) - Fever and Antipyretic in Critically ill Evaluation :phase II randomized controlled trial

The Tokushima University Hospital0 个研究点目标入组 310 人开始时间: 2011年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
310

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Acute brain injury defined as acute traumatic brain injury, subarachnoid haemorrhage, acute ischaemic stroke, acute intracerebral haemorrhage, acute intracranial infection or cardiac arrest 2.The treating clinician expects the patient to have a requirement for an analgaesic regimen containing paracetamol, NSAIDs or COX-2 inhibitors within the next 3 days. 3.Diagnosis of heat stroke, or, malignant hyperthermia, neuroleptic malignant syndrome, or other drug-induced hyperthermia, rhabdomyolysis, and thyrotoxicosis 4.Pregnancy 5.Imminent death (cardiac standstill or brain death anticipated in less than 24 hours) and the treating clinicians are not committed to full supportive care.

研究者

发起方
The Tokushima University Hospital

相似试验